TrialJournal of viral hepatitis2022

240-week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C.

Jing-Hang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.